Oral Formulations For Delivery of Catecholic Butanes Including Ndga Compounds

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20090022803A1
SERIAL NO

11814838

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides for compositions, kits and methods for treatment of diseases, where the compositions contain catecholic butanes, including NDGA compounds, such as NDGA derivatives, for example tetra-O-methyl NDGA. The present invention also provides for solubilizing agents and excipients that are suitable for administration of the present compounds into animals via an oral route, whether in a liquid, semi-solid or solid form.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ERIMOS PHARMACEUTICALS LLC9600 BELLAIRE BOULEVARD SUITE 228 HOUSTON TX 77036

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Blomberg, Jessica Andrea LoDuca Raleigh, US 2 27
Goodman, Amanda Beth Wake Forest, US 1 1
Heller, Jonathan Daniel San Francisco, US 10 99
Lopez, Rocio Alejandra Raleigh, US 10 99
Rhodes, Melissa Claire Raleigh, US 2 27

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation